Bio HQ pharmaceutical biotechnology clinical research life science news biochemistry biotechnology headquarters

The Leading Resource For The Biopharmaceutical Industry

Home
About Us
Biotech/Pharma
Careers
Clinical Trials
FDA
Medicare/Managed Care
New Drug Applications
Regulation
Stock Selection
Contact Us

Hot News

Info Box

Biotechnology/Pharmaceutical News U.S. group questions AstraZeneca's Crestor patent (Reuters) Reuters - A U.S. patent research group says it has uncovered evidence that co... FDA panel: Lower maximum daily dose of Tylenol (AP) AP - Government experts called for sweeping safety restrictions Tuesday on th... Pfizer discontinues Sutent colon cancer study (AP) AP - Pfizer is discontinuing a late-stage study of its cancer drug Sutent (SO... Teva, Antares get FDA OK for hormone in new device (AP) AP - Teva Pharmaceutical Industries Ltd. and Antares Pharma Inc. said Monday ... Dogs helping injured soldiers under gov't program (AP) AP - Army Specialist Cameron Briggs washes down a cocktail of prescription dr... Prescription drugs in spotlight after Jackson death (AFP) AFP - Michael Jackson's death has lifted a veil on the sinister underbelly of... FDA panel backs Ista drug for eye allergies (AP) AP - A panel of federal experts said Friday an anti-itching drug from eye car... U.S. seizes Caraco drugs over manufacturing problems (Reuters) Reuters - U.S. authorities seized generic medicines made by Caraco Pharmaceut... Watson gets FDA approval for generic Plan B (AP) AP - Watson Pharmaceuticals Inc. said Wednesday it recieved Food and Drug Adm... Drug deals cost U.S. consumers $3.5 bln a year: FTC (Reuters) Reuters - Consumers, insurance companies and the federal government spend an ... Obama announces agreement with drug companies (AP) AP - President Barack Obama on Monday welcomed the pharmaceutical industry's ... Baucus, White House in deal with drug industry (AP) AP - The pharmaceutical industry agreed Saturday to spend $80 billion over th...	FDA News FDA Approves Multaq to Treat Heart Rhythm Disorder The U.S. Food and Drug Administration has approved Multaq tablets (dronedaron... FDA: Boxed Warning on Serious Mental Health Events to be Required for Chantix... The U.S. Food and Drug Administration today announced that it is requiring ma... FDA Seeks Public Input on Tobacco Regulation The U.S. Food and Drug Administration announced today that it is seeking publ... FDA Confirms E. Coli O157:H7 in Prepackaged Nestlé Toll House Refrigerated Co... Today, the U.S. Food and Drug Administration announced that it has found E. c... U.S. Attorney News Release: Ringleader Sentenced to Nine Years In Federal Pri... A registered nurse who directed an allergy testing health care fraud scheme, ... Company Recalls Various Products Due to Potential Salmonella Contamination FDA, USDA, CDC investigating; no link to human illnesses at this time. Plain... U.S. Attorney Press Release: Scottsdale Man Pleads Guilty to Multiple Federa... Timothy Keay Isaac, 47, of Scottsdale, Ariz., pleaded guilty earlier this wee... U.S. Marshals Seize Drug Products Manufactured by Caraco Pharmaceutical Labor... U.S. Marshals Seize Drug Products Manufactured by Caraco Pharmaceutical Labor... U.S. Attorney News Release: Former Managing Pharmacist Pleads Guilty To Consp... The former managing pharmacist at a Middlesex County pharmacy pleaded guilty ... FDA Approves Generic Prescription-Only Version of Plan B Emergency Contracept... The U.S. Food and Drug Administration today approved the first generic versio... FDA Seeks Public Input on Transparency The U.S. Food and Drug Administration will host a daylong meeting on June 24,... FDA Warns Consumers Not to Eat California Prime Produce and Orange County Orc... The U.S. Food and Drug Administration is warning consumers not to eat Califor...

New Drug Applications Dermatologic and Ophthalmic Drugs Advisory Committee Unanimously Recommends B... IRVINE, Calif., June 26, 2009 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals,... Takeda Receives FDA Complete Response Letter for Alogliptin, an Investigation... DEERFIELD, Ill., June 26, and OSAKA, Japan, June 27, 2009 /PRNewswire/ -- Tak... Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority R... Completed NDA submission could lead to marketing approval in Q4-2009 SEATTLE,... FDA Appointed Arthritis Advisory Committee Recommends U.S. Food and Drug Admi... EAST BRUNSWICK, N.J., June 16 /PRNewswire-FirstCall/ -- Savient Pharmaceutica... Bioalliance Pharma Submits Loramyc NDA to US FDA And Announces a General Shar... PARIS--(BUSINESS WIRE)--Jun 15, 2009 - BioAlliance Pharma SA (Paris:BIO), a c... FDA Extends Review of Arzerra (ofatumumab) LONDON, June 16, 2009--GlaxoSmithKline and Genmab A/S today announced that th... BioDelivery Sciences Provides NDA Update for Onsolis RALEIGH, N.C.--(BUSINESS WIRE)--Jun 15, 2009 - BioDelivery Sciences Internati... FDA Accepts Final Section of NDA Filing for Lucassin LEBANON, N.J., and CLINTON, N.J., June 12 /PRNewswire/ -- Orphan Therapeutics... Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Revi... RICHMOND, Calif., June 11 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals... NeurogesX Provides U.S. Regulatory Update for Qutenza SAN MATEO, Calif., June 10, 2009 /PRNewswire-FirstCall/ -- NeurogesX, Inc. an...	Clinical Trials Phase III Study Showed Lucentis Improved Vision in Patients with Branch Retin... -- Study Showed Early and Sustained Improvement in Vision Through Six Months ... iCo Therapeutics Publishes Review of Diabetic Retinopathy Treatment VANCOUVER, July 2 /CNW/ - iCo Therapeutics Inc. (TSX-V: ICO) today announced ... Sepracor Provides Update on Clinical Trials for SEP-225289 and LUNESTA Pediat... MARLBOROUGH, Mass.--(BUSINESS WIRE)--Jul 1, 2009 - Sepracor Inc. (Nasdaq: SEP... Lu AA24530 shows positive results in major depressive disorder phase II study COPENHAGEN, July 2, 2009--H. Lundbeck A/S (Lundbeck) today announced positive... Sucampo Reports Top-Line Results of Phase 2 Clinical Trial of Cobiprostone fo... BETHESDA, Md.--(BUSINESS WIRE)--Jul 1, 2009 - Sucampo Pharma Americas, Inc., ... Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM... - Results Demonstrate Positive Proof of Mechanism SAN DIEGO, June 30/PRNewswi... Study Showed Vyvanse (lisdexamfetamine dimesylate) CII Provided Significant E... VYVANSE is the first stimulant to establish duration of efficacy from two hou... Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa Single-dose of investigational sustained follicle stimulant achieves similar ... New Review on Prostvac Published by Key Investigators From NCI KVISTGAARD, Denmark, July 1/PRNewswire-FirstCall/ -- A just published Review ... Pharming Confirms Positive Results From Fina l Analysis Of Rhucin Studies Leiden, The Netherlands, July 1, 2009. Biotech company Pharming Group NV (“Ph...

BIO HQ STOCK SELECTION SERVICE

BIO HQ CAREERS